Roger Herschel Herzig: younger half of the dynamic duo which advanced leukaemia therapy and transplants: January 4, 1946 to July 18, 2020 - Takeaways - MDSpire

Roger Herschel Herzig: younger half of the dynamic duo which advanced leukaemia therapy and transplants: January 4, 1946 to July 18, 2020

  • By

  • Robert Peter Gale

  • Hillard M. Lazarus

  • Gordon L. Phillips

  • September 9, 2020

  • 0 min

Share

  • 1

    Roger Herschel Herzig, a pioneer in leukaemia therapy, passed away on July 18, 2020, leaving a significant impact on the medical community.

  • 2

    He founded the Bone Marrow Transplant Programme at University Hospitals Cleveland Medical Center in 1976, advancing treatment for leukaemia and lymphoma.

  • 3

    Herzig collaborated on over 100 publications, contributing to clinical trials that established key therapies still used today in cancer treatment.

  • 4

    He was a member of several prestigious medical societies and served as an Honorary Professor at the Chinese Academy of Medical Sciences.

  • 5

    Herzig's legacy includes his dedication to patients, mentorship of future physicians, and contributions to international bone marrow transplant programs.

Original Source(s)

Roger Herschel Herzig: younger half of the dynamic duo which advanced leukaemia therapy and transplants: January 4, 1946 to July 18, 2020

  • by Robert Peter Gale, Hillard M. Lazarus, Gordon L. Phillips

  • September 9, 2020

Related Content

CRISPR Enables In Vivo CAR T Cell Production

In vivo gene editing strategy generates CAR T cells directly inside the body – sidestepping costly manufacturing

  • March 30, 2026

  • 2 min
When Adnexal Lymphoma Mimics Retinal Disease

Fertility preservation and subsequent reproductive outcomes in female pediatric patients with hematologic malignancies